Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lowe

Showing results (651-660 of 755) with videos related to

Pageof 76
Sort By:
American Heart Journal|November 4, 2004
Electrocardiographic findings in cardiogenic shock, risk prediction, and the effects of emergency revascularization: results from the SHOCK trialHarvey D White, Sebastian T Palmeri, Lynn A Sleeper, et al.
The British Journal of Dermatology|April 11, 2016
A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipientsA C Chen, A J Martin, R A Dalziell, et al.
Plos One|February 6, 2014
Identification of cinnabarinic acid as a novel endogenous aryl hydrocarbon receptor ligand that drives IL-22 productionMargaret M Lowe, Jeff E Mold, Bittoo Kanwar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 1, 2012
A novel monoclonal antibody to CD40 prolongs islet allograft survivalM Lowe, I R Badell, P Thompson, et al.
Cell Host & Microbe|December 1, 2019
Toxin-Triggered Interleukin-1 Receptor Signaling Enables Early-Life Discrimination of Pathogenic versus Commensal Skin BacteriaJohn M Leech, Miqdad O Dhariwala, Margaret M Lowe, et al.
Lancet (London, England)|September 10, 2013
Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy RegistrySteven E Lipshultz, E John Orav, James D Wilkinson, et al.
Journal of the American College of Cardiology|October 18, 2003
Percutaneous coronary intervention for cardiogenic shock in the SHOCK trialJohn G Webb, April M Lowe, Timothy A Sanborn, et al.
Pathogens (Basel, Switzerland)|May 28, 2022
Virus-Derived Chemokine Modulating Protein Pre-Treatment Blocks Chemokine-Glycosaminoglycan Interactions and Significantly Reduces Transplant Immune DamageIsabela R Zanetti, Michelle Burgin, Liqiang Zhang, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Tertiary Lymphoid Structures Sustain Cutaneous B cell Activity in Hidradenitis SuppurativaMargaret M Lowe, Jarish N Cohen, Madison I Moss, et al.
Plos One|March 25, 2010
The complete genome sequence of Haloferax volcanii DS2, a model archaeonAmber L Hartman, Cédric Norais, Jonathan H Badger, et al.
Pageof 76

Showing results (651-660 of 755) with videos related to

Sort By:
Pageof 76
American Heart Journal|November 4, 2004
Electrocardiographic findings in cardiogenic shock, risk prediction, and the effects of emergency revascularization: results from the SHOCK trialHarvey D White, Sebastian T Palmeri, Lynn A Sleeper, et al.
The British Journal of Dermatology|April 11, 2016
A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipientsA C Chen, A J Martin, R A Dalziell, et al.
Plos One|February 6, 2014
Identification of cinnabarinic acid as a novel endogenous aryl hydrocarbon receptor ligand that drives IL-22 productionMargaret M Lowe, Jeff E Mold, Bittoo Kanwar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 1, 2012
A novel monoclonal antibody to CD40 prolongs islet allograft survivalM Lowe, I R Badell, P Thompson, et al.
Cell Host & Microbe|December 1, 2019
Toxin-Triggered Interleukin-1 Receptor Signaling Enables Early-Life Discrimination of Pathogenic versus Commensal Skin BacteriaJohn M Leech, Miqdad O Dhariwala, Margaret M Lowe, et al.
Lancet (London, England)|September 10, 2013
Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy RegistrySteven E Lipshultz, E John Orav, James D Wilkinson, et al.
Journal of the American College of Cardiology|October 18, 2003
Percutaneous coronary intervention for cardiogenic shock in the SHOCK trialJohn G Webb, April M Lowe, Timothy A Sanborn, et al.
Pathogens (Basel, Switzerland)|May 28, 2022
Virus-Derived Chemokine Modulating Protein Pre-Treatment Blocks Chemokine-Glycosaminoglycan Interactions and Significantly Reduces Transplant Immune DamageIsabela R Zanetti, Michelle Burgin, Liqiang Zhang, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Tertiary Lymphoid Structures Sustain Cutaneous B cell Activity in Hidradenitis SuppurativaMargaret M Lowe, Jarish N Cohen, Madison I Moss, et al.
Plos One|March 25, 2010
The complete genome sequence of Haloferax volcanii DS2, a model archaeonAmber L Hartman, Cédric Norais, Jonathan H Badger, et al.
Pageof 76